Valsartan And Hydrochlorothiazide
Product Images NDC 54868-6440

7 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 54868-6440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label – 320 mg/12.5 mg Rx Only Ndc 0781-5951-92 Valsartan And Hydrochlorothiazide Tablets, Usp 320 mg/12.5 mg Per Tablet 90 Tablets (6440)

Package Label – 320 mg/12.5 mg Rx Only Ndc 0781-5951-92 Valsartan And Hydrochlorothiazide Tablets, Usp 320 mg/12.5 mg Per Tablet 90 Tablets (6440)
The label for Valsartan and Hydrochlorothiazide tablets, USP 320 mg/12.5 mg, contains 30 tablets. It is from Physicians Total Care, Inc., with NDC 54868-6440-0. The label includes dosage information, storage instructions to keep at controlled room temperature, and a notice that federal law prohibits dispensing without a prescription. Expiry and lot number details are also visible on the label.*
FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Valsartan Hct 1)

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Valsartan Hct 1)
A line chart depicting the percentage of patients with systolic blood pressure (SBP) below 140 mmHg across different baseline SBP values ranging from 140 to 180 mmHg. The chart compares four groups: Valsartan and Hydrochlorothiazide 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, with each group represented by distinct symbols on the graph.*
FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Valsartan Hct 2)

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Valsartan Hct 2)
Line graph showing the percentage of patients with diastolic blood pressure (DBP) below 90 mmHg plotted against baseline DBP values ranging from 90 to 110 mmHg. The graph compares four treatments: Valsartan and Hydrochlorothiazide 320/25 mg combination, Valsartan 320 mg alone, Hydrochlorothiazide 25 mg alone, and placebo. Each treatment is represented by distinct markers in a descending trend as baseline DBP increases.*
FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Valsartan Hct 3)

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Valsartan Hct 3)
A line graph depicting the percentage of patients achieving systolic blood pressure (SBP) under 130 mmHg across different baseline SBP levels in mmHg. It compares four groups: Valsartan and Hydrochlorothiazide 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo, using distinct markers for each group.*
FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Valsartan Hct 4)

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Valsartan Hct 4)
A line graph showing the percentage of patients with diastolic blood pressure (DBP) less than 80 mmHg plotted against baseline DBP (90 to 110 mmHg). Four data series represent Valsartan and Hydrochlorothiazide 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, illustrating the efficacy comparison of these treatments in lowering DBP.*
FDA Label Image

Valsartan Chemical Structure (Valsartan Hct 5)

Valsartan Chemical Structure (Valsartan Hct 5)
Chemical structure of valsartan, one of the active ingredients in the combination drug Valsartan and Hydrochlorothiazide by Physicians Total Care, Inc.*
FDA Label Image

Hydrochlorothiazide Chemical Structure (Valsartan Hct 6)

Hydrochlorothiazide Chemical Structure (Valsartan Hct 6)
Chemical structure of Valsartan and Hydrochlorothiazide indicating key functional groups including a sulfonamide moiety, chloro-substituted aromatic ring, and other characteristic chemical bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.